Back to results
RecruitingPhase 3

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

NCT07282600

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Birmingham Clinical Research

Birmingham, Alabama, United States

+158 additional locations

Contact

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

317-615-4559LillyTrials@Lilly.com
View on ClinicalTrials.gov
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes — TrialFind